Heart, Trauma and Sepsis Research Laboratory, College of Medicine & Dentistry, James Cook University, Townsville, Queensland, Australia.
Aarhus University Hospital, Aarhus, Denmark.
J Surg Res. 2020 Sep;253:127-138. doi: 10.1016/j.jss.2020.03.048. Epub 2020 Apr 27.
Noncompressible hemorrhage is the leading cause of preventable death in military and civilian trauma. Our aim was to examine the effect of adenosine, lidocaine, and magnesium (Mg; ALM) on cardiovascular and cerebral function in a porcine hepatic hemorrhage model.
Pigs (59.1 ± 0.34 kg) were anesthetized, instrumented, and randomly assigned into sham (n = 6), saline controls (n = 10) or ALM (n = 10) groups before laparoscopic liver resection. After 30 min, groups received 4 mL/kg 3% NaCl ± ALM bolus (Phase 1) followed 60 min later with 3 mL/kg/h 0.9% NaCl ± ALM drip (4 h; Phase 2), then transfusion. Hemodynamics, carotid artery flow, and intracranial pressure were measured continuously. Microdialysis samples were analyzed for metabolites.
Saline controls had 20% mortality (mean survival time: 307 ± 38 min) with no ALM deaths over 6 h. Bolus administration increased mean arterial pressure (MAP) in both groups, and drip led to further increases to 62 ± 10 mmHg in controls compared with a steady fall to 47 ± 8 mmHg in ALM group at 240 min. The lower MAP was associated with a dramatic fall in systemic vascular resistance and improved oxygen delivery. ALM drip significantly increased cardiac output and stroke volume with lower dP/dt, indicating a less stiff heart. ALM drip also significantly decreased cerebral perfusion pressure, reduced cerebral oxygen consumption (28%), and reduced brain glycerol (60%), lactate (47%), and relative expression of hypoxia-inducible factor (38%) compared with saline controls.
ALM therapy improved cardiac function and oxygen delivery by lowering systemic vascular resistance after noncompressible hemorrhage. ALM also appeared to protect the brain at hypotensive MAPs with significantly lower cerebral perfusion pressure, lower O consumption, and significantly lower cortical lactate and glycerol levels compared to saline controls.
非压迫性出血是军事和平民创伤中可预防死亡的主要原因。我们的目的是研究腺嘌呤、利多卡因和镁(Mg;ALM)在猪肝脏出血模型中对心血管和脑功能的影响。
猪(59.1±0.34kg)麻醉、仪器操作,并在腹腔镜肝切除前随机分为假手术组(n=6)、生理盐水对照组(n=10)或 ALM 组(n=10)。30 分钟后,各组给予 4mL/kg 3%NaCl±ALM 推注(第 1 阶段),60 分钟后给予 3mL/kg/h 0.9%NaCl±ALM 滴注(4 小时;第 2 阶段),然后输血。连续测量血流动力学、颈总动脉血流和颅内压。分析微透析样本中的代谢物。
生理盐水对照组有 20%的死亡率(平均存活时间:307±38 分钟),而在 6 小时内无 ALM 死亡。推注使两组的平均动脉压(MAP)升高,滴注导致对照组的 MAP 在 240 分钟时进一步升高至 62±10mmHg,而 ALM 组的 MAP 则稳定下降至 47±8mmHg。较低的 MAP 与全身血管阻力的急剧下降和氧输送的改善有关。ALM 滴注可显著增加心输出量和每搏量,同时降低 dP/dt,表明心脏更柔软。ALM 滴注还可显著降低脑灌注压,降低脑氧消耗(28%),并降低脑甘油(60%)、乳酸(47%)和缺氧诱导因子的相对表达(38%)与生理盐水对照组相比。
ALM 治疗通过降低非压迫性出血后的全身血管阻力来改善心脏功能和氧输送。与生理盐水对照组相比,ALM 似乎还能在较低的 MAP 下保护大脑,使脑灌注压显著降低,O 消耗显著降低,皮质乳酸和甘油水平显著降低。